Medicine | Oncology
CNS Tumors | Gliomas
High-grade gliomas
Follow-up, Quality of life, Symptom management

Home > Disciplines > Medicine > Oncology > CNS Tumors > Gliomas > High-grade gliomas > Follow-up, Quality of life

VALPROIC ACID

Botturi A, Silvani A, Pravettoni G, Paoli RA, Lucchiari C.
Reversible Valproate Induced Pisa Syndrome and Parkinsonism in a Neuro-Oncology Patient with Depression and Epilepsy.
Case Rep Neurol. 2016 Jun 6;8(2):115-9. doi: 10.1159/000446643. eCollection 2016 May-Aug.
Source | Abstract | Full text | Similar articles

Watanabe S, Kuwabara Y, Suehiro S, Yamashita D, Tanaka M, Tanaka A, Ohue S, Araki H.
Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma.
Eur J Clin Pharmacol. 2016 Nov 26. [Epub ahead of print]
Source | Abstract | Full text | Similar articles

SYMPTOM MANAGEMENT

.

Siegel C, Armstrong TS.
Nursing Guide to Management of Major Symptoms in Patients with Malignant Glioma.
Semin Oncol Nurs. 2018 Dec;34(5):513-527. doi: 10.1016/j.soncn.2018.10.014. Epub 2018 Nov 10.
Source | Full text | Similar articles

Recurrent tumors

.

Liu Y, Feng F, Ji P, Liu B, Ge S, Yang C, Lou M, Liu J, Li B, Gao G, Qu Y, Wang L.
Improvement of health related quality of life in patients with recurrent glioma treated with bevacizumab plus daily temozolomide as the salvage therapy.
Clin Neurol Neurosurg. 2018 Mar 27;169:64-70. doi: 10.1016/j.clineuro.2018.03.026. [Epub ahead of print]
Source | Abstract | Full text | Similar articles

Stöckelmaier L, Renovanz M, König J, Nickel K, Hickmann AK, Mayer-Steinacker R, Nadji-Ohl M, Ganslandt O, Bullinger L, Wirtz CR, Coburger J.
Therapy for recurrent high-grade gliomas: Results of a prospective multicenter study on health-related quality of life.
World Neurosurg. 2017 Mar 10. pii: S1878-8750(17)30234-6. doi: 10.1016/j.wneu.2017.02.061. [Epub ahead of print]
Source | Abstract | Full text | Similar articles

CARMUSTINE

.

Yerram P, Reiss SN, Modelevsky L, Gavrilovic IT, Kaley T.
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol. 2019 Aug 20. doi: 10.1007/s11060-019-03266-0. [Epub ahead of print]
Source . Similar articles